15.4 C
New York
Wednesday, April 24, 2024
HomeMarkets
Markets

Benzinga’s Daily Biotech Pulse: Realm Therapeutics To List On Nasdaq, CASI Pharma Added To Russell 2000 Index

By Insider Scoop
0
72
psw-placeholder
psw-placeholder

Courtesy of Benzinga.

Benzinga's Daily Biotech Pulse: Realm Therapeutics To List On Nasdaq, CASI Pharma Added To Russell 2000 Index

Here’s a roundup of top developments in the biotech space since Tuesday morning.

Scaling the Peaks

(Stocks hitting 52-week highs on July 3)

  • Arbutus Biopharma Corp (NASDAQ: ABUS)
  • Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR)
  • BioLife Solutions Inc (NASDAQ: BLFS)
  • Merus NV (NASDAQ: MRUS)
  • Regenxbio Inc (NASDAQ: RGNX)
  • SurModics, Inc. (NASDAQ: SRDX)
  • Veracyte Inc (NASDAQ: VCYT)
  • Zafgen Inc (NASDAQ: ZFGN)

Down In The Dumps

(Stocks hitting 52-week lows on July 3)

  • Autolus Therapeutics Ltd – ADR (NASDAQ: AUTL)
  • Curis, Inc. (NASDAQ: CRIS)
  • Erytech Pharma SA (ADR) (NASDAQ: ERYP)
  • Neos Therapeutics Inc (NASDAQ: NEOS)
  • Opiant Pharmaceuticals Inc (NASDAQ: OPNT)
  • TrovaGene Inc (NASDAQ: TROV)
  • ZEALAND PHARMA/S ADR (NASDAQ: ZEAL)

Related Link: Attention Biotech Investors: Mark Your Calendar For These July PDUFA Dates

Stocks In Focus

Realm ADS to Begin Trading On Nasdaq

Realm Therapeutics PLC (NASDAQ: RLM), which develops therapies for immune-related diseases, said the SEC has declared effective registration statements on Form F-1 and F-6 with respect to the ADSs, representing its ordinary shares, that are to be listed on the Nasdaq.

The company said the ADSs will begin trading on the Nasdaq under the ticker symbol RLM on Thursday.

Currently, shares of the company are listed on the AIM, a U.K. exchange for small and growing companies.

CASI Added to the Russell 2000 Index

CASI Pharmaceuticals Inc (NASDAQ: CASI) said its stock has been added to the Russell 2000, 3000 as well as the Microcap Indexes, effective after the close of market on June 22.

Posted-In: Biotech News Top Stories Pre-Market Outlook Trading Ideas Best of Benzinga

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments

Stay Connected

157,326FansLike
396,312FollowersFollow
2,290SubscribersSubscribe

Latest Articles

Load more

Note: The material presented in this commentary is provided for informational purposes only and is based upon information that is considered to be reliable. However, neither PSW Investments, LLC d/b/a PhilStockWorld (PSW) nor its affiliates warrant its completeness, accuracy or adequacy and it should not be relied upon as such. Neither PSW nor its affiliates are responsible for any errors or omissions or for results obtained from the use of this information. Past performance, including the tracking of virtual trades and portfolios for educational purposes, is not necessarily indicative of future results. Neither Phil, Optrader, or anyone related to PSW is a registered financial adviser and they may hold positions in the stocks mentioned, which may change at any time without notice. Do not buy or sell based on anything that is written here, the risk of loss in trading is great.

This material is not intended as an offer or solicitation for the purchase or sale of any security or other financial instrument. Securities or other financial instruments mentioned in this material are not suitable for all investors. Any opinions expressed herein are given in good faith, are subject to change without notice, and are only intended at the moment of their issue as conditions quickly change. The information contained herein does not constitute advice on the tax consequences of making any particular investment decision. This material does not take into account your particular investment objectives, financial situations or needs and is not intended as a recommendation to you of any particular securities, financial instruments or strategies. Before investing, you should consider whether it is suitable for your particular circumstances and, as necessary, seek professional advice.

Contact us: support@philstockworld.com

© Copyright - PSW, LLC.

2024
0
Would love your thoughts, please comment.x
()
x